first large study of glp 1 receptor agonists during pregnancy PDF) GLP-1 Agonist Use in Technology advances in diabetes pregnancy:

Notably, the majority of HF patients in our analysis had HFpEF, which limits the generalizability of our findings to those with HF with reduced EF, and we observed a more pronounced reduction in HF hospitalizations among obese compared with nonobese individuals and that HF patients experienced a greater reduction in infection risk with GLP-1 RAs compared with those without HF

PMID: 37269475 Animals and Zoonoses2025 May 31

Healing Different Tissues: A Comparison Table In 2026, we know that these peptides do not work equally on all tissues

The choice between them for glycemic control alone would likely favor tirzepatide simply because it is available and proven, while retatrutide remains investigational

The quality of the sequencing reads of gbuB amplicons was checked using fastp (v0.23.0), employing the default parameters

Janocha AJ, Comhair S, Basnyat B, Neupane M, Gebremedhin A, Khan A, et al